PrP mRNa and protein expression in brain and PrPc in CSF in Creutzfeldt-Jakob disease MM1 and VV2

Prion

Volumn 7, Issue 5, 2013, Pages 383-393

  Llorens, Franc ^a,b,c   Ansoleaga, Belén ^a,b   Garcia Esparcia, Paula ^a,b   Zafar, Saima ^c   Grau Rivera, Oriol ^d   López González, Irene ^a,b   Blanco, Rosi ^a,b   Carmona, Margarita ^a,b   Yagüe, Jordi ^d   Nos, Carlos ^e   Del Río, José Antonio ^b,f   Gelpí, Ellen ^g   Zerr, Inga ^c   Ferrer, Isidre ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^d HOSPITAL CLÍNIC   (Spain)

^e General Subdirectorate of Surveillance and Response to Emergencies in Public Health   (Spain)

^f UNIVERSITY OF BARCELONA   (Spain)

^g INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Brain; Cerebrospinal fluid; Creutzfeldt Jakob disease; mRNA; Neurodegenerative diseases; Prion protein

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; METHIONINE; PRION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VALINE;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN DEGENERATION; CEREBELLUM; CEREBROSPINAL FLUID; COGNITIVE DEFECT; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DIFFUSE LEWY BODY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTAL CORTEX; FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL LOBE DEGENERATION; GENE MUTATION; GLIOSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PURIFICATION;

BRAIN; CEREBROSPINAL FLUID; CREUTZFELDT-JAKOB DISEASE; MRNA; NEURODEGENERATIVE DISEASES; PRION PROTEIN;

CREUTZFELDT-JAKOB SYNDROME; FRONTAL LOBE; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; PRIONS; PRPC PROTEINS; RNA, MESSENGER;

EID: 84887829791     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.26416     Document Type: Article

References (33)

1. Aguzzi A, Sigurdson C, Heikenwaelder M. Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 2008;3:11-40; PMID:18233951; http://dx.doi.org/10. 1146/annurev. pathmechdis.3.121806.154326
2. Colby DW, Prusiner SB. Prions. Cold Spring Harb Perspect Biol 2011;3:a006833; PMID:21421910; http://dx.doi.org/10.1101/cshperspect.a006833
3. Aguzzi A, Heikenwalder M, Polymenidou M. Insights into prion strains and neurotoxicity. Nat Rev Mol Cell Biol 2007;8:552-61; PMID:17585315; http://dx.doi.org/10.1038/nrm2204
4. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AA, Trojanowski JQ, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996;39:767-78; PMI D:8651649; http://dx.doi.org/10.1002/ana.410390613
5. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-33; PMID:10443888; http://dx.doi.org/10.1002/ 1531-8249 (199908) 46:2<224::AID-A NA12 >3.0. CO;2-W
6. Head MW, Ironside JW. Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain. Neuropathol Appl Neurobiol 2012;38:296-310; PMID:22394291; http://dx.doi. o r g/10.1111/j.1365-2990. 2012. 01265. x
7. Parchi P, Saverioni D. Molecular pathology, classification, and diagnosis of sporadic human prion disease variants. Folia Neuropathol 2012;50:20-45; PM ID:22505361
8. Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 2012;11:618-28; PMID:22710755; http://dx.doi.org/10.1016/S1474-4422 (12) 70063-7
9. Herms J, Tings T, Gall S, Madlung A, Giese A, Siebert H, Schürmann P, Windl O, Brose N, Kretzschmar H. Evidence of presynaptic location and function of the prion protein. J Neurosci 1999;19:8866-75; PM ID:10516306
10. Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell 1993;73:1339-47; PMID:8100741; http://dx.doi.org/10.1016/0092-8674 (93) 90360-3
11. Riemenschneider M, Wagenpfeil S, Vanderstichele H, Otto M, Wiltfang J, Kretzschmar H, Vanmechelen E, Förstl H, Kurz A. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol Psychiatry 2003;8:343-7; PMID:12660807; http://dx.doi.org/10. 1038/sj.mp. 4001220
12. Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Sáanchez-Valle R, Mitrováa E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006;67:637-43; PMID:16924018; http://dx.doi.org/10.1212/01. wnl.0000230159.67128.00
13. Weber T, Otto M, Bodemer M, Zerr I. Diagnosis of Creutzfeldt-Jakob disease and related human spongiform encephalopathies. Biomed Pharmacother 1997;51:381-7; PMID:9452787; http://dx.doi.org/10.1016/S0753-3322 (97) 89430-9
14. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998;43:32-40; PMID:9450766; http://dx.doi.org/10.1002/ana.410430109
15. Wong BS, Green AJ, Li R, Xie Z, Pan T, Liu T, Chen SG, Gambetti P, Sy MS. Absence of proteaseresistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease. J Pathol 2001;194:9-14; PMID:11329135; http://dx.doi.org/10.1002/path.872
16. Meyne F, Gloeckner SF, Ciesielczyk B, Heinemann U, Krasnianski A, Meissner B, Zerr I. Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders. J Alzheimers Dis 2009;17:863-73; PM ID:19542614
17. Torres M, Cartier L, Matamala JM, Hernández N, Woehlbier U, Hetz C. Altered Prion protein expression pattern in CSF as a biomarker for Creutzfeldt-Jakob disease. PLoS One 2012;7:e36159; PMID:22558368; http://dx.doi.org/10.1371/journal.pone.0036159
18. Esiri MM, Carter J, Ironside JW. Prion protein immunoreactivity in brain samples from an unselected autopsy population: findings in 200 consecutive cases. Neuropathol Appl Neurobiol 2000;26:273-84; PMID:10886685; http://dx.doi.org/10.1046/j.1365-2990.2000.00239.x
19. Sørby R, Austbø L, Press CM, Skretting G, Landsverk T, Espenes A. PrP expression, PrPSc accumulation and innervation of splenic compartments in sheep experimentally infected with scrapie. PLoS One 2009;4:e6885; PMID:19727393; http://dx.doi.org/10.1371/journal.pone.0006885
20. Rudd PM, Endo T, Colominas C, Groth D, Wheeler SF, Harvey DJ, Wormald MR, Serban H, Prusiner SB, Kobata A, et al. Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc Natl Acad Sci U S A 1999;96:13044-9; PMID:10557270; http://dx.doi.org/10.1073/pnas.96.23.13044
21. Winklhofer KF, Heller U, Reintjes A, Tatzelt J. Inhibition of complex glycosylation increases the formation of PrPsc. Tra f f ic 2003;4:313-22; PMID:12713659; http://dx.doi.org/10.1034/j.1600-0854.2003.00088.x
22. Cancellotti E, Bradford BM, Tuzi NL, Hickey RD, Brown D, Brown KL, Barron RM, Kisielewski D, Piccardo P, Manson JC. Glycosylation of PrPC determines timing of neuroinvasion and targeting in the brain following transmissible spongiform encephalopathy infection by a peripheral route. J Virol 2010;84:3464-75; PMID:20106922; http://dx.doi.org/10.1128/JVI.02374-09
23. Cancellotti E, Mahal SP, Somerville R, Diack A, Brown D, Piccardo P, Weissmann C, Manson JC. Post-translational changes to PrP alter transmissible spongiform encephalopathy strain properties. EMBO J 2013;32:756-69; PMID:23395905; http://dx.doi.org/10.1038/emboj.2013.6
24. Ferrer I, Puig B, Blanco R, Martí E. Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease. Neuroscience 2000;97:715-26; PMID:10842016; http://dx.doi.org/10.1016/ S0306-4522 (00) 00045-2
25. Ferrer I, Rivera R, Blanco R, Martí E. Expression of proteins linked to exocytosis and neurotransmission in patients with Creutzfeldt-Jakob disease. Neurobiol Dis 1999;6:92-100; PMID:10343324; http://dx.doi.org/10.1006/ nbdi.1998.0226
26. Jeffrey M, McGovern G, Sisó S, González L. Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease. Acta Neuropathol 2011;121:113-34; PMID:20532540; http://dx.doi.org/10. 1007/s00401-010-0700-3
27. Corsaro A, Thellung S, Villa V, Nizzari M, Florio T. Role of prion protein aggregation in neurotoxicity. Int J Mol Sci 2012;13:8648-69; PMID:22942726; http://dx.doi.org/10.3390/ijms13078648
28. Simoneau S, Rezaei H, Salès N, Kaiser-Schulz G, Lefebvre-Roque M, Vidal C, Fournier JG, Comte J, Wopfner F, Grosclaude J, et al. In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog 2007;3:e125; PMID:17784787; http://dx.doi.org/10.1371/journal.ppat.0030125
29. Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloidbeta oligomers. Nature 2009;457:1128-32; PMID:19242475; http://dx.doi.org/10.1038/ nature07761
30. Um J W, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 2012;15:1227-35; PMID:22820466; http://dx.doi.org/10.1038/n n. 3178
31. Kudo W, Lee HP, Zou WQ, Wang X, Perry G, Zhu X, Smith MA, Petersen RB, Lee HG. Cellular prion protein is essential for oligomeric amyloid-β- induced neuronal cell death. Hum Mol Genet 2012;21:1138-44; PMID:22100763; http://dx.doi.org/10.1093/hmg/ddr542
32. Larson M, Sherman MA, Amar F, Nuvolone M, Schneider JA, Bennett DA, Aguzzi A, Lesné SE. The complex PrP (c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's disease. J Neurosci 2012;32:16857-71a; PMID:23175838; http://dx.doi.org/10.1523/JNEUROSCI.1858-12. 2012
33. Windl O, Giese A, Schulz-Schaeffer W, Zerr I, Skworc K, Arendt S, Oberdieck C, Bodemer M, Poser S, Kretzschmar HA. Molecular genetics of human prion diseases in Germany. Hum Genet 1999;105:244-52; PMID:10987652; http://dx.doi.org/10.1007/s004390051096